Hepatopulmonary syndrome: the paradigm of liver-induced hypoxaemia.
The current chapter deals with the concept, clinical manifestations and diagnostic tools of the hepatopulmonary syndrome (HPS) and highlights its most salient pathophysiological, mechanistic and therapeutic aspects. Defined as a clinical triad, including a chronic liver disorder, pulmonary gas exchange abnormalities and generalized pulmonary vascular dilatations, in the absence of intrinsic cardiopulmonary disease, this entity is currently growing in interest with both clinicians and surgeons. The combination of arterial hypoxaemia, high cardiac output with normal or low pulmonary artery pressure, and finger clubbing in a patient with advanced liver disease should strongly suggest the diagnosis of HPS. Its potential high prevalence together with failure of numerous therapeutic approaches depicts a life-threatening unique clinical condition that may dramatically benefit with an elective indication of liver transplantation (LT). A better orchestration of the concepts of the pathophysiology of this lung-liver interplay may foster our knowledge and improve the clinical management and indications of LT.
Rodriguez-Roisin
R
R
Departament de Medicina, Hospital Clínic, Universitat de Barcelona, Spain.
Roca
J
J
D003937:Diagnosis, Differential; D006801:Humans; D000860:Hypoxia / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D017093:Liver Failure / Q000150:complications* / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery; D016031:Liver Transplantation; D015995:Prevalence; D011652:Pulmonary Circulation; D013577:Syndrome; D014692:Ventilation-Perfusion Ratio